ANBIO BIOTECHNOLOGY

Watch

Share

NNNN·G0367B105·US·Common Stock·Healthcare - Medical Instruments & Supplies

NNNN (ANBIO BIOTECHNOLOGY) is held by 5 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($661,851), BNP PARIBAS FINANCIAL MARKETS ($267,176), MORGAN STANLEY ($188,513). Net institutional sentiment: Bullish.

13F: Mar 31, 2026Insider & Congress: Updated regularly

Positions (5)History

AllNewIncreasedHeldDecreasedExited

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
GEODE CAPITAL MANAGEMENT, LLC	Unchanged	25,763	$661,851	0.0%	-43.04%	0
BNP PARIBAS FINANCIAL MARKETS	Increased	10,400(+940.0%)	$267,176	0.0%	-60.90%	38
MORGAN STANLEY	Increased	7,338(+261x)	$188,513	0.0%	-59.44%	25
UBS Group AG	Increased	6,339(+122.5%)	$162,849	0.0%	-61.62%	25
WELLS FARGO & COMPANY/MN	Unchanged	100	$2,569	0.0%	-69.91%	0

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

413 holders · $666.6B

UNHUNITEDHEALTH GROUP INC

413 holders · $186.3B

JNJJOHNSON & JOHNSON

394 holders · $391.3B

DHRDANAHER CORP DEL

392 holders · $97B

ISRGINTUITIVE SURGICAL INC

391 holders · $123.5B

TMOTHERMO FISHER SCIENTIFIC INC

391 holders · $147B

BSXBOSTON SCIENTIFIC CORP

389 holders · $76.8B

MRKMERCK & CO INC

385 holders · $208.9B

ABBVABBVIE INC

381 holders · $254.9B

ABTABBOTT LABORATORIES

380 holders · $129.1B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer